Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0364T
|
Adaptive behavior treatment by protocol administered by technician face-to-face with one patient; first 30 minutes of technician time
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0364U
|
Oncology (hematolymphoid neoplasm) genomic sequence analysis using multiplex (PCR) and next-generation sequencing with algorithm quantification of dominant clonal sequence(s) reported as presence or absence of minimal residual disease (MRD) with quantitation of disease burden when appropriate
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0365T
|
Adaptive behavior treatment by protocol administered by technician face-to-face with one patient; each additional 30 minutes of technician time (List separately in addition to code for primary procedure)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0365U
|
Oncology (bladder) analysis of 10 protein biomarkers (A1AT ANG APOE CA9 IL8 MMP9 MMP10 PAI1 SDC1 and VEGFA) by immunoassays urine algorithm reported as a probability of bladder cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0366T
|
Group adaptive behavior treatment by protocol administered by technician face-to-face with two or more patients; first 30 minutes of technician time
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0366U
|
Oncology (bladder) analysis of 10 protein biomarkers (A1AT ANG APOE CA9 IL8 MMP9 MMP10 PAI1 SDC1 and VEGFA) by immunoassays urine algorithm reported as a probability of recurrent bladder cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0367T
|
Group adaptive behavior treatment by protocol administered by technician face-to-face with two or more patients; each additional 30 minutes of technician time (List separately in addition to code for primary procedure)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0367U
|
Oncology (bladder) analysis of 10 protein biomarkers (A1AT ANG APOE CA9 IL8 MMP9 MMP10 PAI1 SDC1 and VEGFA) by immunoassays urine diagnostic algorithm reported as a risk score for probability of rapid recurrence of recurrent or persistent cancer following transurethral resection
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0368T
|
Adaptive behavior treatment with protocol modification administered by physician or other qualified health care professional with one patient; first 30 minutes of patient face-to-face time
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0368U
|
Oncology (colorectal cancer) evaluation for mutations of APC BRAF CTNNB1 KRAS NRAS PIK3CA SMAD4 and TP53 and methylation markers (MYO1G KCNQ5 C9ORF50 FLI1 CLIP4 ZNF132 and TWIST1) multiplex quantitative polymerase chain reaction (qPCR) circulating cell-free DNA (cfDNA) plasma report of risk score for advanced adenoma or colorectal cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0369T
|
Adaptive behavior treatment with protocol modification administered by physician or other qualified health care professional with one patient; each additional 30 minutes of patient face-to-face time (List separately in addition to code for primary procedure)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0369U
|
Infectious agent detection by nucleic acid (DNA and RNA) gastrointestinal pathogens 31 bacterial viral and parasitic organisms and identification of 21 associated antibiotic-resistance genes multiplex amplified probe technique
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0370T
|
Family adaptive behavior treatment guidance administered by physician or other qualified health care professional (without the patient present)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0370U
|
Infectious agent detection by nucleic acid (DNA and RNA) surgical wound pathogens 34 microorganisms and identification of 21 associated antibiotic-resistance genes multiplex amplified probe technique wound swab
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0371T
|
Multiple-family group adaptive behavior treatment guidance administered by physician or other qualified health care professional (without the patient present)
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0371U
|
Infectious agent detection by nucleic acid (DNA or RNA) genitourinary pathogen semiquantitative identification DNA from 16 bacterial organisms and 1 fungal organism multiplex amplified probe technique via quantitative polymerase chain reaction (qPCR) urine
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0372T
|
Adaptive behavior treatment social skills group administered by physician or other qualified health care professional face-to-face with multiple patients
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0372U
|
Infectious disease (genitourinary pathogens) antibiotic-resistance gene detection multiplex amplified probe technique urine reported as an antimicrobial stewardship risk score
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0373T
|
Exposure adaptive behavior treatment with protocol modification requiring two or more technicians for severe maladaptive behavior(s); first 60 minutes of technicians' time face-to-face with patient
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0373U
|
Infectious agent detection by nucleic acid (DNA and RNA) respiratory tract infection 17 bacteria 8 fungus 13 virus and 16 antibiotic-resistance genes multiplex amplified probe technique upper or lower respiratory specimen
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.